Veluba is a zero-emission transport solution for London. It is an application-hailed and pedal-powered eco-cab service for Central London which aims to provide a faster and cheaper solution for its over-polluted and over-congested capital city. The company has 30 Veluba cabs ready to go with and have just launched their app. The vehicles are designed and driven with safety at the forefront and drivers are fully insured. Each Veluba® is provided with digital signage screens, giving prominent ad space, and the possibility for an additional revenue stream. Veluba aims to expand beyond the first depot to reach more of London and become a key part of the city’s growing eco-transport infrastructure. The investment will enable the company to employ additional drivers.
days to go:
Expired
investment:
£78,590
Vaboo is a customisable perks and engagement platform for the private rented sector. The platform allows clients to enhance their brand image and add value to their service through engaging communication, giveaways, and prize draws, designed to attract customers to the platform on a regular basis. Addressing core problems of the sector, Vaboo not only helps clients built their brand value, it also offers them a competitive edge in the market. By April 2019, 350+ agency branches will have brought 50,000+ renters on to the platform. Moreover, Vaboo is estimated to achieve at least a 10% market share (approx. 2000 branches) which will generate annual recurring revenues of over £4m. With the fund raised, Vaboo will focus on team expansion, product development, and sales.
days to go:
Expired
investment:
£172,077
The world's first automated suturing tools for safe closure of standard and endoscopic wounds. Sutrue have already patented their devices and use industry-standard needles to offer clinical quality with improved speed and accuracy at the touch of a button. Needles are held in disposable cartridges as a safety feature to prevent injury when piercing skin with contaminated needles. This protects staff both during and after surgery for those working in medical and veterinary environments.
Sutrue is raising finance for the production process of their equipment, as well as applying for CE regulation via medical evaluations to receive approval to deploy their products in human and animal surgeries.
days to go:
Expired
investment:
Withheld
MET Homes provides an off-the-shelf modern construction method (MMC) for housing, aiming to make MMC financially viable at lower production volumes, which addresses an identified market gap. Their system utilizes 13 pre-engineered and factory-assembled load-bearing wall and floor panels, suitable for constructing residential new builds up to three stories high. With a selection of 13 panels, MET Homes has developed over 50 house types in different widths, lengths, and roof styles, offering versatility for construction projects.
days to go:
Expired
investment:
£110,602
Rightangled is a DNA testing company backed by NHS that delivers services to consumers and medical/fitness specialists. The company is a full CQC healthcare provider license that has achieved registration with Bupa, a leading medical insurance company. The company is now planning to move into AI with a solid database. Rightangled has received excellent customer reviews with 5* on Google and 4.5* on Trustpilot. With the proceeds, the company will seek to launch its application, create a strong AI central system, and grow into new markets (US& UAE).
days to go:
Expired
investment:
£311,690
FreeHand is a robotic surgical camera controller that aims to make surgeries precise and safer. The company cites data arguing that over 15 million keyhole surgeries are performed annually in which an additional clinician is mostly required to manually hold the camera the surgeon uses to see the operating field. The company asserts that this is not the most optimal way. FreeHand's robotic camera controller aims to solve this issue by providing steady images and precise control, saving time, and improving outcomes. The company has regulatory clearance for sale in the EU, US, and Japan. FreeHand points out that surgical robotics is one of the fastest-growing segments in Medical Technology, projected to reach $91.5 billion by 2025. It aims to become a contender in this segment. FreeHand claims that surgeons have successfully used its robotic controller in more than 15,000 procedures. The company will use the investment to expand the distributor base in Europe, Asia and Latin America, targeting over 12 million procedures annually.
days to go:
Expired
investment:
£1,003,350
Trecento Diagnostics, with the help of a molecular testing system complete, they are now ready to launch a patent-pending collection device named HygieCatch®. It is a non-invasive, needle-free examination, in the vet practice providing DNA extraction from urine onsite with a report within 40 minutes of extraction of the sample. The company has identified partners in the UAE and US and is also in early-stage discussions with UK vet practices. Furthermore, for the purpose of commercialisation of HygieCatch & the technology used, alongside addition of new tests including Lyme disease the company is planning to raise its capital.
days to go:
Expired
investment:
£167,910
Buzzbike is a disruptive new way for brands to advertise around the city, putting thousands of bikes on the road along the way. Each bike is fully branded which allows Buzzbikes partners to design a full fleet of bikes. To maximise impact, bikes are clustered and geo-targeted in places the brand wants to be seen by recruiting riders who work and park in those locations. Buzzbikes are completely free for the rider, all you have to do is ride to work a minimum of 12 times a month and street park. They are also giving away lock, lights, insurance and yearly servicing, as well as a discount at their kit partner Brooks.
days to go:
Expired
investment:
£388,870
The developer has secured full planning consent for the demolition of an old milk processing factory and development of 49 residential units and one commercial unit, pre-let to the Co-op on a 15 year lease. The residential development will comprise 39 private units (1 bed flats, 2 bed maisonettes, 3 and 4 bed houses) and 10 affordable units where a sale has already been pre-agreed. The scheme will also include car parking, cycle storage and landscaping.
days to go:
Expired
investment:
Withheld
